Having established that PIK3R1 loss activates STAT3 and AKT pathways in ovarian cancer cells, we reasoned that cells with PIK3R1 loss would be sensitive to inhibitors of these two pathways. The gene discussed is STAT3; the disease is ovarian cancer.